Abstract:Background Human autosomal dominant polycystic kidney disease (ADPKD) is characterized by bilateral renal cysts that lead to a decline in kidney function over time. Previous studies reported aquaporin‐3 (AQP3) expression in cysts derived from collecting ducts in ADPKD. Methods To study the contribution of AQP3 in cyst development, two PKD mouse models, kidney‐specific Pkd1 knockout mice and inducible Pkd1 knockout mice, were generated with or without AQP3 deletion. MDCK cell line was used to study the mechanism in which AQP3 affected cyst development. Results Kidney size and cyst index were significantly smaller in AQP3‐null PKD mice than those in AQP3‐expressing PKD mice, with the difference due mainly to a smaller diameter of collecting duct cysts. AQP3 deficiency inhibits cystogenesis in inducible PKD mice. Importantly, AQP3 deficiency reduced the number of cysts from collecting duct (9.3±1.1 vs. 2.7±0.6) and their diameter. The diameter of AQP3‐MDCK cysts was significantly ~38% larger than in control MDCK cells. The percentage of AQP3‐MDCK cells that formed cysts was significantly lower than in control MDCK cells. AQP3 promoted cyst epithelia cells proliferation. Western‐blot analyses revealed that the expression levels of proliferating cell nuclear antigen (PCNA) in AQP3‐null PKD were reduced as compared with the PKD mice. Consistent with the results in vivo, intracellular ATP in AQP3 null kidney was 75% of that in AQP3‐expressing kidney. We found lower level of AMPK phosphorylation in AQP3‐MDCK cells as compared to MDCK cells. In vivo, the p‐AMPK in AQP3 null kidney was 2.4‐fold more than that in wild‐type kidney. The level of p‐AMPK in PKD mouse kidney was half of which in wild‐type control kidney. AQP3 gene deletion in PKD mice reversed the p‐AMPK level. AQP3 null kidney produced a significant increase in phosphorylated ACC (p‐ACC) levels. We found that S6 phosphorylation in AQP3‐MDCK cells was about 1.6 times as MDCK cells. Western blot revealed that p‐S6 in AQP3 null kidney was 17.7% of that in wild‐type kidney. The level of p‐S6 in PKD mouse kidney was 1.8 fold greater than that in wild‐type mouse kidney. AQP3 gene deletion in PKD mice reversed the p‐S6 to a normal level. The expression of GLUT1 was upregulated and expression of HIF1α was also increased in AQP3‐MDCK cells. These results suggest that AQP3 promotes glucose uptake by increasing GLUT1 expression. Indeed, glucose deprivation abrogated the decrease of p‐AMPK of AQP3‐MDCK cells. Conclusion The experimental results indicate that AQP3 depletion retards cyst growth in part as a consequence of impaired AQP3‐dependent energy metabolism. These findings identify AQP3 as a potential target to reduce cyst development in ADPKD. Support or Funding Information This work was supported by National Natural Science Foundation of China grants 31200869, 81261160507, 81330074 and 81170632, and the 111 Project. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Inositol 1,4,5-Triphosphate Receptor 3 Promotes Renal Cyst Development in Autosomal Dominant Polycystic Kidney Disease

Aquaporin‐3 Deficiency Slows Renal Cystogenesis Via Regulation of AMPK/ERK/mTOR Signaling

Aquaporin‐3 Deficiency Slows Cyst Enlargement in Experimental Mouse Models of Autosomal Dominant Polycystic Kidney Disease

Aquaporin-3 Deficiency Slows Renal Cyst Growth by Impairment of Glucose Metabolism Via AMPK/ERK/mTOR Signaling

Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease

Activation of PIEZO1 Inhibits Kidney Cystogenesis

Protein Kinase A Downregulation Delays the Development and Progression of Polycystic Kidney Disease

Inhibiting Focal Adhesion Kinase Ameliorates Cyst Development in Polycystin-1-Deficient Polycystic Kidney Disease in Animal Model

Protein Phosphatase 1α Interacts with a Novel Ciliary Targeting Sequence of Polycystin‐1 and Regulates Polycystin‐1 Trafficking

Pkhd1 Gene Silencing May Cause Cell Abnormal Proliferation Through Modulation Of Intracellular Calcium In Autosomal Recessive Polycystic Kidney Disease

Activation of PIEZO1 Attenuates Kidney Cystogenesis In Vitro and Ex Vivo

Up-Regulation of DNA Damage Response Signaling in Autosomal Dominant Polycystic Kidney Disease

CD74 Promotes Cyst Growth and Renal Fibrosis in Autosomal Dominant Polycystic Kidney Disease

Inhibiting centrosome clustering reduces cystogenesis and improves kidney function in autosomal dominant polycystic kidney disease

TRAF3 Delays Cyst Formation Induced by NF‐κB Signaling

Repulsive Guidance Molecule B Inhibits Renal Cyst Development Through the Bone Morphogenetic Protein Signaling Pathway.

Overexpression of SMYD3 Promotes Autosomal Dominant Polycystic Kidney Disease by Mediating Cell Proliferation and Genome Instability

Modulation of Polycystic Kidney Disease Severity by Phosphodiesterase 1 and 3 Subfamilies

[Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)]

Aquaporin‐1 Retards Renal Cyst Development in Polycystic Kidney Disease by Inhibition of Wnt Signaling

Quercetin inhibits renal cyst growth in vitro and via parenteral injection in a polycystic kidney disease mouse model.